Beau wrote:
Going off on what BTDT mentioned, here is an in-depth answer for endocrine/metabolic effects obtained from Micromedex. The results from the clinical trials for trazodone hydrochloride oral tablets (Apotex Corp) should be listed in the product info (you know...that package insert sheet with a bunch of fine print words listing practically everything about the medication).
Weight gain
a) Incidence: 1.4% to 4.5% [34]
b) Weight gain has been reported in 1.4% to 4.5% of trazodone recipients (n=299) compared with 0% to 1.9% of placebo recipients (n=253) in clinical trials [34].
Weight loss
a) Incidence: up to 5.7% [34]
b) Weight loss has been reported in up to 5.7% of trazodone recipients (n=299) compared with 2.5% to 3.2% of placebo recipients (n=253) in clinical trials [34].
[34] Product Information: trazodone hydrochloride oral tablets, trazodone hydrochloride oral tablets. Apotex Corp., Weston, FL, 2009.
As you can see, 1.4%-4.5% of 299 trazodone recipients experienced weight gain during the trial, which is approximately 4-13 people in a sample size of 299. If your physician informed you that you will not gain any weight, then that's misleading according to the evidence. However, there is a small likelihood that you will depending on other factors, like genes, concurrent medications etc.
That sucks because I really need to have some appeal and something that makes me marketable to the opposite gender.
_________________
“There’s a lesson that we learn
In the pages that we burn
It’s written in the ashes of the fire below”
-Down, The Birthday Massacre